Kent Hawryluk is the founder of MBX Biosciences. Latest round: Seed. Backed by The Indiana Philanthropic Venture Fund (IU PhV), Indiana Seed Fund III.
Kent Hawryluk is a Co-Founder of MBX Biosciences, Inc., recognized for building biopharma companies and pioneering Precision Endocrine Peptides (PEPs). He served as President and Chief Executive Officer of MBX Biosciences from January 2020 until July 2026.
Full founder directory · Investor directory · Company funding database · Fundraising library